Bonum Therapeutics
banner
bonumtx.com
Bonum Therapeutics
@bonumtx.com
25 followers 52 following 18 posts
Systemic Delivery, Local Activity: Bonum uses a novel, antibody-based mechanism to create regulated and targeted, highly active and less toxic medicines. 🔗 https://bonumtx.com/
Posts Media Videos Starter Packs
Bonum has secured a key U.S. patent protecting the unique mechanism of action behind our Dual-Binding Antibody (DBA) platform, covering marker-specific binding pairs such as LRRC15-IFNa, PD-L1-IFNa, PD1-IL2, and more.

Read more about this exciting milestone: www.businesswire.com/news/home/20...
Explore the next frontier in biologics at #BIO2025 with Bonum, Lumanity, Polaris Partners, @regeneron.com, Tentarix & Werewolf.

“Beyond Bispecifics & ADCs: Conditionally Active Biologics”
📍 Boston Convention & Exhibition Center, 206AB
🗓️ June 18 | 10:15–11:15 a.m. | 206AB

More: ow.ly/OBCa50W7aJO
This #NationalCancerResearchMonth, Bonum joins the research community in honoring the scientists, clinicians, advocates & patients advancing cancer care. This year’s theme—#UnitedByCancerResearch: One Mission. One Voice.—is a powerful reminder that breakthroughs happen when we work together. #NCRM25
Chicago did not disappoint! Members of the Bonum team had a fantastic time at the #AACR25 Annual Meeting connecting with peers, partners, and pioneers in cancer research.

Thanks to @theaacr.bsky.social for bringing the global oncology community together in the Windy City.

#TargetedTherapeutics
Startup life can be challenging, but for Cindy Yee, VP of Preclinical Development at @bonumtx.com, it’s been incredibly rewarding. Going from large orgs to a tight-knit team, she shares insights and lessons from the #biotech front lines for those eyeing a #startup. Check it out: ow.ly/b9JV50VstjN
Today, we proudly celebrate the 10th anniversary of the International Day of Women and Girls in Science! At Bonum Therapeutics, we recognize the critical role that women and girls play in science and technology each and every day. 🔬🧬

#WomenInScience #GirlsInStem #Steminist
#FBF: Revisiting "In the Pink" at #JPM2025, a celebration of the contributions of women leaders in biotech & pharma—and their allies. Can you spot CBO Neela Patel & VP Cindy Yee in the #SeaOfPink?

Thanks to Biotech CEO Sisterhood, #Breaking7% & @cooleyllp.bsky.social for sponsoring! #ProjectMirror
The Bonum team will be on winter break from December 24 to January 1. We look forward to reconnecting in 2025. Wishing you and yours a safe and joyful holiday season!
Bonum's Linda Liang, Senior Dir. of Antibody Discovery, is featured in this month's Life Science Washington Executive Perspective! Learn how Linda & her team are discovering new molecules for therapeutics to revolutionize cancer treatment: lifesciencewajobs.com/2024/12/16/e...

#FindYourBestLifeinWA
We recently announced the appointment of Samuel Blackman, MD, PhD, to our board of directors as an independent director. His expertise & guidance will be instrumental in advancing Bonum's programs into the clinic.

Please join us in welcoming Sam to the Bonum team!

Full Release: ow.ly/I7yb50UjSSw
Bonum is proud to announce a $93M Series A financing to advance our conditionally active therapies. We're honored that all investors who backed our team at Good Therapeutics have continued their support, and we’ve welcomed a new investor to the syndicate:

ow.ly/OOqk50LEACt
Welcome to the next chapter for the Good Therapeutics team -- introducing Bonum Therapeutics (@BonumTx)!

linkedin.com/pulse/welcome-…
We are excited to announce that @Roche has acquired Good Therapeutics’ innovative conditionally active PD-1-regulated-IL-2 program. The Good Therapeutics team has formed a new company, Bonum Therapeutics (@BonumTx). Learn more here:

ow.ly/QBxB50KC0ey